0000874015-25-000018.txt : 20250106 0000874015-25-000018.hdr.sgml : 20250106 20250106165231 ACCESSION NUMBER: 0000874015-25-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250102 FILED AS OF DATE: 20250106 DATE AS OF CHANGE: 20250106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Devers Shannon L. CENTRAL INDEX KEY: 0002037721 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 25511987 MAIL ADDRESS: STREET 1: C/O IONIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2025-01-02 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0002037721 Devers Shannon L. 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP, Chief Human Resources Ofc 0 Non-Qualified Stock Option (right to buy) 34.69 2025-01-02 4 A 0 22000 0.0 A 2026-01-02 2035-01-01 Common Stock 22000 22000 D Grant on 01/02/2025 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/02/2025. 25% of the shares subject to the option will vest and become exercisable on 01/02/2026. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years. By: Patrick R. O'Neil, attorney-in-fact For: Shannon L. Devers 2025-01-03